{"name":"Caribou Biosciences, Inc.","slug":"caribou-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Caribou-sponsored investigational therapy","genericName":"Caribou-sponsored investigational therapy","slug":"caribou-sponsored-investigational-therapy","indication":"Treatment of sickle cell disease","status":"phase_2"}]}],"pipeline":[{"name":"Caribou-sponsored investigational therapy","genericName":"Caribou-sponsored investigational therapy","slug":"caribou-sponsored-investigational-therapy","phase":"phase_2","mechanism":"This investigational therapy targets the CRISPR-Cas12 system to modulate gene expression.","indications":["Treatment of sickle cell disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5VWmlkSnMycl9jN1Q1eDVlRXBSUlRZNkZCSlV0Rko3eVZ0cU1KWlVPakhEbWVQaHAwbXNaaVFjazFPWUJmZnRhMnVNTjJmWXZzWGpHZkhqVk83ZzBtQmNr?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"CRBU Stock Price, Quote & Chart | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill","headline":"CRBU Stock Price, Quote & Chart | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1vN0ZSV0Y5Nnd2a1NBZVZSeFZNZU1Uakstamd3eDhnZjVkRG84cWlPRGphRm5UTnYyNWd0cDhmTVJZMHNnTDNSQVduRHFqeVF0WnBIdDNJN1JwMDVOaWRyWlBuRkpyOFd5Tl84M2VIYlNvZHlfSGFLRQ?oc=5","date":"2026-02-27","type":"deal","source":"U.S. News Money","summary":"7 Top Gene-Editing Stocks to Buy - U.S. News Money","headline":"7 Top Gene-Editing Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOU0g4SjJqdWdJMHhfaHdCNWIxajNJeGtkcHllVnlwc1lWT1BOakdIYzlKRU9WdkRoV1hsMzJrdldXUGtYYTMwTkZpWlVydnpOM1NTOGgyT09WOW1ZNThNd2NFREFnd3RKc1RwVFM2V2lRel9oLXpjakFWZ0c1blc0U0t1U1lLNTl2RmFyeGp0cXY1YWYwNXlVVHA0S0FsR1lhSDFBaUJPSGNPSWpJZzVablhxM2VPbGE4SHBHTnYzbHVtVHdaVWItTA?oc=5","date":"2026-02-21","type":"deal","source":"The Globe and Mail","summary":"Caribou Biosciences (CRBU) Receives a Buy from Citi - The Globe and Mail","headline":"Caribou Biosciences (CRBU) Receives a Buy from Citi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOODlBMHhna3haZWJKdTkyZGpsT1Z2NkxnS0dsekI0cHNJRjBXUG00Q3dPTGNQZWZOQkZaSkpnSTlLNzRURy1WRmtUMm5VYUYtd2Z3X25fbEFNeThuNXlyeENfSVR2TlJQX3A3c3pkeDJ6ZS1vd2FNcjdWY0RhTUlaUVRIQmp6Q1RQaWRqemtZNW1iZnJhLVdRc01HNm1oTEFoVndoRG16OXQ?oc=5","date":"2026-02-12","type":"pipeline","source":"investingnews.com","summary":"Caribou Biosciences to Participate in Upcoming Investor Conferences - investingnews.com","headline":"Caribou Biosciences to Participate in Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNdENwcmtzNDZLcU5yM2cxUEJjOC1MbDNYYUhtXzNxeDA0VkV4aFUwTE80Q2xtaWtSOURha0VKZXYwQ25UQWdESU52cU1JWUxRVFVqYl9fQXExV3h0UGZ6OHRsbzAxcmxfMUo4M3RIOEZicXpBWkktbUNMOC00dGZ4Rk1Tb1hzUERrUGNQdk13NU1EWUo3MEhMd2NXaTFxbnk1S3c?oc=5","date":"2025-11-03","type":"pipeline","source":"BioPharma Dive","summary":"Caribou results suggest renewed promise for ‘off-the-shelf’ cancer cell therapy - BioPharma Dive","headline":"Caribou results suggest renewed promise for ‘off-the-shelf’ cancer cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdloydmJfbEc1MlhsU3JRcklib0lxZWlWYzhNYmxnajdLeHp5WHBaUnRZVlN2UXRuS2tYY2ZvV0lHdklVaFlOUjQ4WmNnSW1IYmxseE5LaXRITzdqX01tWTNGQ3E5UFp4RTM1aWVxclBFTzdaSDBMdnl1cUNCZVlWU0dJTjh4Z25iemtnNVFtaS0xbHZG?oc=5","date":"2025-11-03","type":"trial","source":"The Pharma Letter","summary":"Caribou Bio leaps on early data for vispa-cel - The Pharma Letter","headline":"Caribou Bio leaps on early data for vispa-cel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOSGZaM19GR05Hdy1yY3lTS1ZGMDY2UThXSWx2LVVhUWh0N2xYTnYwdXNFU0wxRHo3alQ1T1hDZWdYZWZsbVliSXM1YXNzekprTEZPcnF3U3lYUS1aYzYwdlZ0SEprLWlFWE5vb3poZVo0ZWJnOW4zWmJHcWZYYmRyX05KdS05S0liUjJ6dGcyenBrNktkdWtWZS1BbUd1VGVNb21CYWpPWk9qc0JScHVrUzNPN1hZbVlzUUpycmxyWWtoWHc1ZDZCSU1mN1k3RExjM3BQdUthOFNiQTRxYUVVZzBLSUY1S2toR05uSjQ1U0NNVGNxNXM5WkN1cldVTWZ2dDJ3S2lOYWs3bzJHNU9lVDBWYXBzU0tF?oc=5","date":"2025-10-02","type":"trial","source":"GlobeNewswire","summary":"CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"CRISPR Therapies Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPSGhnWkIwbTRiS1BnbmdtSFhqR0QzbU4xUFQ4bnpQekdjMWdXVW1xYXVja214b2JXOGNCNV9VYVBJRDEyS0pzaGtfekxXRzZyd1M2bXpnclRMdzFYWUZvODVJSzJXcHJJUzNXRFo3ODhOQmhRc2hiMktKTDNFVjFfdUszaE8wdWFwMThDOUsxeUFyZU1XMi1Xb0dRTVFnRV9IcExRWUc5R1BZTDZjNFpObkE1TnFzdWdOQkxWcXFWSVQzLXFqNVlqMUNsUWlnUVlkOTQtU1dOUGlrN25vSXd2LUEyZDNuSGxSQVd4ZEhoRTdDM28tRmdXdzl5eHhDaG50Tzl0TWZJdW0?oc=5","date":"2025-08-27","type":"pipeline","source":"prnewswire.com","summary":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight - prnewswire.com","headline":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPcHpYOUlqSDYtRVJoZVV4TUo1NlFEOG54ekxlVFdjdnpnM2dPUUtlQmFMWGtmM00zMXpSMHhrRDk0TDJHdVNaMEtqZnlsRXVHc2ttVjZ4YWlpS0hHaW1qVnZWNlg2dkQtV25IQkFPMjBXbzNFYjAxZGpnUW52TExsSFgxeHF2VDJkOThybzhPY3M4RnBxamMtNVVSblZsTTlTVWJMTG92RkJPM2ND?oc=5","date":"2025-04-25","type":"pipeline","source":"BioPharma Dive","summary":"Caribou, in reversal, scraps autoimmune cell therapy and cuts staff - BioPharma Dive","headline":"Caribou, in reversal, scraps autoimmune cell therapy and cuts staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOeWVrX0gtWW1vdHI4TzFTaEotbEg4bS1BM1U5ZkFSVHhMNS1SRDRFc1N2NTluX2hYN0M2WW5BRUFNNnB0NUJlcXh5MXBac3paUHpmVk9UWXpIeE1iWmZhUUZiZ1R4RG9KYXpyOERFNVZpdm9qenNpb0FRU0pfWGVuR2txNGVXeVh5bngtRVdXZzFEQTNJSUdrVjJWUWRuX3FqUFM1UzdRaGx6LXh2VFI0ODM2RHBfZTJYVVE?oc=5","date":"2025-04-24","type":"pipeline","source":"Fierce Biotech","summary":"Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects - Fierce Biotech","headline":"Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQUHBUSVR6VHdhdzd4OFRpbDNINWswcE9RQWRQaUpHa2lMMy1hckVjamJlRVg0VmNVWmE1d3AxUVNfS28yOXhwVU9JanVHWTA2RklHdTJFaTlJRXIwQmZ5VzFpNVp6N1pZMU5fQnJkOEp5Ujc2TGFoWVZKRDcxQ0tKS2NILTI?oc=5","date":"2024-12-30","type":"pipeline","source":"Yahoo Finance","summary":"Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In? - Yahoo Finance","headline":"Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQZXNZTkVWVG5YLTZxaDBwNlBPd3RvdnU2dVdaVDlwcnB2Z1VOMjVIdU1tTUNJTmdtcWRETWUtN1d6TnNycmcxTF8yNFFqdEFBRE5QVWNvZFEyX2ZGQnhPM3pVVEZhNk1wZUx3ZzhRQlpBRXpTZF9rQlZQeEdhLVlZQ1NZT0JwZkhkSDNzR2JSMHM?oc=5","date":"2023-07-06","type":"pipeline","source":"Contract Pharma","summary":"Pfizer Invests $25M in Caribou Biosciences - Contract Pharma","headline":"Pfizer Invests $25M in Caribou Biosciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}